• View Cart
  • FAQs
  • LOG IN
Biotech Primer WEEKLY
  • Home
  • Training Options
    • Customized Onsite Training
    • Live, Online 1 & 2-Day Master Courses
    • On-Demand, Online 60-Minute Classes
    • Master Course Recordings
    • Corporate Learning
  • About Us
    • Our Expertise
    • Our Experience
    • Our Clients
    • Contact Us
  • Our Publications
    • The WEEKLY Newsletter
    • 2020 WEEKLY Compendium
    • 2015-2020 Quinquennial
      Compendium
    • Biotech Primer Book
    • Biotech for Non-Scientists Course SnapShot
    • Online Course Snapshot
    • Medical Device Course Snapshot
    • Drug Development Course SnapShot
    • Manufacturing Course SnapShot
Select Page
Interchangability Denied To First US Approved Biosimilar

Interchangability Denied To First US Approved Biosimilar

by Emily Burke, PhD | Mar 12, 2015 | Regulation

G-CSF: The original Innovator Sandoz’s (Princeton, NJ) Zarzio rode the first wave into the U.S. biosimilars market after it received FDA approval last week. Zarzio is similar to Amgen’s (Thousand Oaks, CA) Neupogen and both of these medications are...

About Biotech Primer

From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.

In a hurry? Take our online classes today.

Subscribe to The WEEKLY

Contact Us | Privacy Policy | Biotech Primer © 2021